Trials / Completed
CompletedNCT00395486
ROMEO (Rosuvastatin in Metabolic syndrOme)
A 6-week, Randomised, Open-label, Parallel Group, Multi-centre Study to Compare the Efficacy of Rosuvastatin 10mg With Atorvastatin 10mg in the Treatment of Metabolic Syndrome Subjects With Raised LDL-C
- Status
- Completed
- Phase
- Phase 4
- Study type
- Interventional
- Enrollment
- 258 (actual)
- Sponsor
- AstraZeneca · Industry
- Sex
- All
- Age
- 18 Years
- Healthy volunteers
- Not accepted
Summary
The primary objective of this study is to compare the effect of rosuvastatin 10mg with atorvastatin 10mg after 6 weeks of treatment in the ratio of ApoB/ApoA1 in subjects with metabolic syndrome.
Conditions
Interventions
| Type | Name | Description |
|---|---|---|
| DRUG | Rosuvastatin | 10mg |
| DRUG | Atorvastatin | 10mg |
Timeline
- Start date
- 2006-09-01
- Primary completion
- 2008-06-01
- Completion
- 2008-06-01
- First posted
- 2006-11-03
- Last updated
- 2011-07-11
- Results posted
- 2011-06-16
Locations
3 sites across 1 country: South Korea
Source: ClinicalTrials.gov record NCT00395486. Inclusion in this directory is not an endorsement.